Flavio has a BSc in Biochemistry and MSc in Drug Discovery and Pharmaceutical Management, both from the University College London. In his studies, he has written academic essays on the future of personalised medicine such as autologous CAR-T cell therapies and has recently spoken at the Innate Killer Summit Europe 2022, discussing the landscape of innate immune cell therapies.